Positive results from clinical trials exploring algal DHA presented at 10th Congress of ISSFAL

Research presented by Susan E Carlson, at the Department of Dietetics and Nutrition at the University of Kansas Medical Center indicated that prenatal algal DHA supplementation (600 mg of DHA from 14 weeks gestation until delivery) increased DHA blood levels in both the mother and newborn, as well as infant birth weight, length and head circumference.

Additionally, results presented from a study led by Kelly Mulder, and Sheila Innis, both from the Department of Pediatrics, Child and Family Research Institute at the University of British Columbia, suggest that DHA deficiency during pregnancy may limit infants’ development potential.

John Colombo, PhD, presented data from the DHA Intake and Measurement of Neural Development (DIAMOND) clinical trial, which investigated whether DHA and ARA supplemented infant formula affects children’s cognitive performance from 18 months to six years of age. Results from the study indicated that DHA and ARA supplementation provided developmental benefits evident to six years of age.

EP News Bureau — Mumbai

Comments (0)
Add Comment